Andres Y. Maldonado
Stock Analyst at HC Wainwright & Co.
(4.33)
# 385
Out of 5,055 analysts
19
Total ratings
61.11%
Success rate
18.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Y. Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCRX TScan Therapeutics | Maintains: Buy | $10 → $7 | $1.10 | +536.36% | 1 | Nov 13, 2025 | |
| TERN Terns Pharmaceuticals | Upgrades: Buy | $20 | $22.56 | -11.35% | 1 | Nov 4, 2025 | |
| SNDX Syndax Pharmaceuticals | Reiterates: Buy | $40 | $16.62 | +140.67% | 2 | Oct 27, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterates: Buy | $40 | $11.07 | +261.34% | 2 | Oct 20, 2025 | |
| MRUS Merus | Downgrades: Neutral | $135 → $97 | $96.01 | +1.03% | 1 | Sep 30, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $23 | $4.64 | +395.69% | 1 | Sep 29, 2025 | |
| MNPR Monopar Therapeutics | Maintains: Buy | $70 → $105 | $78.04 | +34.55% | 2 | Sep 29, 2025 | |
| SRRK Scholar Rock Holding | Maintains: Buy | $50 → $44 | $37.41 | +17.62% | 1 | Sep 23, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $41.01 | +82.88% | 3 | Sep 15, 2025 | |
| ENGN enGene Holdings | Reiterates: Buy | $25 | $8.53 | +193.08% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.08 | +284.62% | 1 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $5.53 | +297.83% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $17.26 | +15.91% | 1 | Aug 8, 2025 |
TScan Therapeutics
Nov 13, 2025
Maintains: Buy
Price Target: $10 → $7
Current: $1.10
Upside: +536.36%
Terns Pharmaceuticals
Nov 4, 2025
Upgrades: Buy
Price Target: $20
Current: $22.56
Upside: -11.35%
Syndax Pharmaceuticals
Oct 27, 2025
Reiterates: Buy
Price Target: $40
Current: $16.62
Upside: +140.67%
Corbus Pharmaceuticals Holdings
Oct 20, 2025
Reiterates: Buy
Price Target: $40
Current: $11.07
Upside: +261.34%
Merus
Sep 30, 2025
Downgrades: Neutral
Price Target: $135 → $97
Current: $96.01
Upside: +1.03%
Candel Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $23
Current: $4.64
Upside: +395.69%
Monopar Therapeutics
Sep 29, 2025
Maintains: Buy
Price Target: $70 → $105
Current: $78.04
Upside: +34.55%
Scholar Rock Holding
Sep 23, 2025
Maintains: Buy
Price Target: $50 → $44
Current: $37.41
Upside: +17.62%
CG Oncology
Sep 15, 2025
Reiterates: Buy
Price Target: $75
Current: $41.01
Upside: +82.88%
enGene Holdings
Sep 12, 2025
Reiterates: Buy
Price Target: $25
Current: $8.53
Upside: +193.08%
Sep 10, 2025
Reiterates: Buy
Price Target: $8
Current: $2.08
Upside: +284.62%
Aug 13, 2025
Reiterates: Buy
Price Target: $22
Current: $5.53
Upside: +297.83%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $20
Current: $17.26
Upside: +15.91%